Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06851975 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment

Study acronym: BEST
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Phase: Not applicable to Not specifiedv2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Research into biomarkers predictive of survival and response to cancer treatment
Trial Details
NCT Number NCT06851975
Lead Sponsor Centre Antoine Lacassagne
Conditions
(from sponsor)
Cancer
Related terms Neoplasms
Enrollment 40,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov